GLIORESOLVE TRANSLATIONAL RESEARCH SYMPOSIUM TO TAKE PLACE ON 30 SEPT & 1 OCT 2024

The GLIORESOLVE Virtual Symposium ‘Translational Research in Glioblastoma: from Bench to Bedside’ will take place on Microsoft Teams on the 30th Sept and 1st October 2024.

The programme, featuring 13 invited experts (8 GLIORESOLVE PIs and 5 external guests) covers diverse aspects of translational research with a focus on glioblastoma. On the 30th Sept, morning talks include those focussed on biobanking, tissue analysis, and innovative preclinical research (in vivo, ex vivo and organ-on-a-chip models). In the afternoon, the presentations focus on the development of medical devices, technology transfer/IP and the development process of small molecule drugs in an SME. We finish with a case study reviewing the translational development of oncolytic viral therapy.

On Day 2 (1st October) the focus moves to early phase clinical trials. The first speaker will review Glioma trials in Ireland, and this is followed by two early phase GBM trial case studies (one US and one EU trial). The event will finish with a discussion focusing on the differences in regulatory aspects of clinical trials between the US and the EU.

The event is free to attend and you should register your interest here. A link to join the event (Microsoft Teams) will be emailed to you one week in advance.